Patents by Inventor Robert Peter Gajewski

Robert Peter Gajewski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7772425
    Abstract: The present invention relates to novel, non-secosteroidal, diaryl compounds with vitamin D receptor (VDR) modulating activity that are less hypercalcemic than 1?,25 dihydroxy vitamin D3. These compounds are useful for treating bone disease and psoriasis.
    Type: Grant
    Filed: May 22, 2009
    Date of Patent: August 10, 2010
    Assignee: Eli Lilly and Company
    Inventors: Emilio Enrique Bunel, Robert Peter Gajewski, Charles David Jones, Jianliang Lu, Tianwei Ma, Sunil Nagpal, Ying Kwong Yee
  • Patent number: 7750184
    Abstract: The present invention relates to novel, non-secosteroidal, sulfonate and sulfonamide functional diaryl compounds with vitamin D receptor (VDR) modulating activity that are less hypercalcemic than 1?,25 dihydroxy vitamin D3. These compounds are useful for treating bone disease and psoriasis.
    Type: Grant
    Filed: November 8, 2004
    Date of Patent: July 6, 2010
    Assignee: Eli Lilly and Company
    Inventors: Robert Peter Gajewski, Charles David Jones, Jared Harris Linebarger, Jianliang Lu, Tianwei Ma, Sunil Nagpal, Ying Kwong Yee
  • Patent number: 7601850
    Abstract: The present invention relates to novel, non-secosteroidal, phenyl-thiophene compounds with vitamin D receptor (VDR) modulating activity that are less hypercalcemic than 1?,25 dihydroxy vitamin D3. These compounds are useful for treating bone disease and psoriasis.
    Type: Grant
    Filed: May 22, 2003
    Date of Patent: October 13, 2009
    Assignee: Eli Lilly and Company
    Inventors: Karl Robert Dahnke, Robert Peter Gajewski, Charles David Jones, Jared Harris Linebarger, Jianliang Lu, Tianwei Ma, Sunil Nagpal, Todd Parker Simard, Ying Kwong Yee, Emilio Enrique Bunel, Ryan Edward Stites
  • Patent number: 7595345
    Abstract: The present invention relates to novel, non-secosteroidal, hydroxyl substituted, carbon-linked diaryl compounds with vitamin D receptor (VDR) modulating activity that are less hypercalcemic than 1?,25 dihydroxy vitamin D3. These compounds are useful for treating bone disease and psoriasis.
    Type: Grant
    Filed: November 16, 2004
    Date of Patent: September 29, 2009
    Assignee: Eli Lilly and Company
    Inventors: Emilio Enrique Bunel, Robert Peter Gajewski, Charles David Jones, Jianliang Lu, Sunil Nagpal, Tianwei Ma, Ying Kwong Yee
  • Publication number: 20090227604
    Abstract: The present invention relates to novel, non-secosteroidal, diaryl compounds with vitamin D receptor (VDR) modulating activity that are less hypercalcemic than 1a,25 dihydroxy vitamin D3. These compounds are useful for treating bone disease and psoriasis.
    Type: Application
    Filed: May 22, 2009
    Publication date: September 10, 2009
    Inventors: Emilio Enrique Bunel, Robert Peter Gajewski, Charles David Jones, Jianliang Lu, Tianwei Ma, Sunil Nagpal, Ying Kwong Yee
  • Publication number: 20090018058
    Abstract: The present invention relates to novel, non-secosteroidal, diaryl compounds with vitamin D receptor (VDR) modulating and psoriasis.
    Type: Application
    Filed: November 20, 2003
    Publication date: January 15, 2009
    Applicant: ELI LILLY AND COMPANY
    Inventors: Emilio Enrique Bunel, Robert Peter Gajewski, Charles David Jones, Jianliang Lu, Tianwei Ma, Sunil Nagpal, Ying Kwong Yee
  • Patent number: 7468449
    Abstract: The present invention relates to novel, non-secosteroidal, phenyl-furan compounds with vitamin D receptor (VDR) modulating activity that are less hypercalcemic than 1?,25dihydroxy vitamin D3. These compounds are useful for treating bone disease and psoriasis.
    Type: Grant
    Filed: November 16, 2004
    Date of Patent: December 23, 2008
    Assignee: Eli Lilly and Company
    Inventors: Robert Peter Gajewski, Charles David Jones, Jianliang Lu, Tianwei Ma, Sunil Nagpal, Ying Kwong Yee
  • Publication number: 20080200552
    Abstract: The present invention relates to novel, non-secosteroidal, hydroxyl substituted, carbon-linked diaryl compounds with vitamin D receptor (VDR) modulating activity that are less hypercalcemic than 1?,25 dihydroxy vitamin D3. These compounds are useful for treating bone disease and psoriasis.
    Type: Application
    Filed: November 16, 2004
    Publication date: August 21, 2008
    Applicant: ELI LILLY AND COMPANY
    Inventors: Emilio Enrique Bunel, Robert Peter Gajewski, Charles David Jones, Jianliang Lu, Sunil Nagpal, Tianwei Ma, Ying Kwong Yee
  • Patent number: 6559170
    Abstract: Compounds of formula (One) wherein A1, A2, A3, and A4 independently H, halogen, or methyl; E is —N═ or —CH═; G is O═ or S═; J is —O—, —NH— or —NT1— wherein T1 is alkyl having 1 to 6 carbon atoms; L1, L2, and L3 are independently H, halogen, cyano, methyl, monohalomethyl, dihalomethyl, or trihalomethyl; M is —S—, —S—(═O), or —S(═O)2—); and Q is aryl, substituted aryl, heteroaryl, or substituted heteroaryl. The compounds are useful as fungicides.
    Type: Grant
    Filed: May 23, 2002
    Date of Patent: May 6, 2003
    Assignee: Dow AgroScience LLC
    Inventors: Robert Peter Gajewski, Neil Vincent Kirby, Brent Jeffrey Rieder, Chrislyn Marie Carson, Zhengyu Huang, Stephen Lewis Wilson
  • Patent number: 4118574
    Abstract: A class of 1,4-diphenyl-3-pyrazolin-5-ones are useful as herbicides. The compounds have small alkyl substituents at the 2-position, and the phenyl rings may be substituted as well.
    Type: Grant
    Filed: November 10, 1977
    Date of Patent: October 3, 1978
    Assignee: Eli Lilly and Company
    Inventors: James Richard Beck, Robert Peter Gajewski
  • Patent number: 4075003
    Abstract: A class of 1,4-diphenyl-3-pyrazolin-5-ones are useful as herbicides. The compounds have small alkyl substituents at the 2-position, and the phenyl rings may be substituted as well.
    Type: Grant
    Filed: September 20, 1976
    Date of Patent: February 21, 1978
    Assignee: Eli Lilly and Company
    Inventors: James Richard Beck, Robert Peter Gajewski
  • Patent number: 4065463
    Abstract: A small class of 2-methyl-4-phenyl-5-isoxazolinones are herbicides. The phenyl ring is substituted in the meta position. The compounds are particularly useful as pre-emergence herbicides.
    Type: Grant
    Filed: September 27, 1976
    Date of Patent: December 27, 1977
    Assignee: Eli Lilly and Company
    Inventors: James Richard Beck, Robert Peter Gajewski
  • Patent number: 4012388
    Abstract: A class of new 4-pyrimidinones and thiones have a small alkyl group at the 1-position and a substituted phenyl group at the 5-position. The compounds are herbicides.
    Type: Grant
    Filed: December 11, 1975
    Date of Patent: March 15, 1977
    Assignee: Eli Lilly and Company
    Inventors: James Richard Beck, Robert Peter Gajewski
  • Patent number: 4000155
    Abstract: A small class of 2-methyl-4-phenyl-5-pyrazolinones and isoxazolinones are herbicides. The phenyl rings are substituted in the meta position. The compounds are particularly useful as preemergence herbicides.
    Type: Grant
    Filed: December 11, 1975
    Date of Patent: December 28, 1976
    Assignee: Eli Lilly and Company
    Inventors: James Richard Beck, Robert Peter Gajewski